表紙
市場調查報告書
商品編碼
1025193

關節內粘稠補充療法市場:2021∼2027年

Viscosupplementation System Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球關節內粘稠補充療法的市場規模,在預測期間內預計以約8.6%的年複合成長率擴大。關節內粘稠補充療法,是為了緩和骨關節炎的影響所使用的手術法。全球的變形性膝關節症增加,微創手術的需求,老年人增加等,是在預測期間內活化關節內粘稠補充療法市場的主要原因。再加上醫療基礎設施的改善和關節內粘稠補充療法相關認識度的提高,預期帶給全球關節內粘稠補充療法市場大幅成長。

另一方面,預計政府的嚴格法規和拒絕關節內粘稠補充療法產品加入保險的增加,妨礙全球關節內粘稠補充療法市場。

本報告提供關節內粘稠補充療法市場相關調查,市場概要,以及各產品,各用途,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 規則

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
  • 重要的策略分析
  • 對主要參與者的COVID-19的影響

第4章 市場決策要素

  • 動機
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 全球關節內粘稠補充療法市場,各產品
    • 單注
    • 三注
    • 五注
  • 全球關節內粘稠補充療法市場,各用途
    • 膝關節
    • 髖關節
    • 腳踝關節
    • 其他(肩膀,脊樑骨)

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他

第7章 企業簡介

  • Anika Therapeutics, Inc.
  • Ferring B.V.
  • Fidia Farmaceutici S.p.A
  • Johnson & Johnson Services, Inc.
  • KalVista Pharmaceuticals, Inc.
  • LG Chem(Life Sciences)
  • Lifecore Biomedical, LLC
  • Maxigen Biotech, Inc.
  • Pharmascience Inc.(PendoPharm)
  • Regen Lab SA
  • Sanofi S.A.
  • Seikagaku Corp.
  • Shanghai Haohai Biological Technology Co., Ltd.
  • Smith & Nephew PLC
  • Stellar Pharmaceuticals, Inc.
  • Stryker Corp.
  • Swiss Biomed Orthopaedics AG
  • Virchow Biotech Pvt. Ltd.
  • Zimmer Biomet Holdings, Inc.
目錄
Product Code: OMR2023501

Global Viscosupplementation System Market Size, Share & Trends Analysis Report by Product (Single-Injection, Three-Injection, and Five-Injection) By Application (Knee, Hip, Ankle, and Others) Forecast 2021-2027

The global viscosupplementation market is anticipated to grow at a CAGR of around 8.6% during the forecast period. Viscosupplementation is a surgical technique that is used to relieve the effects of osteoarthritis. It is a non-invasive technique that involves injecting lubricating fluid into joints, also known as hyaluronic acid injections. The technique mainly designed to reduce joint pain and improve the condition of osteoarthritis joints such as the knee, hip, foot, shoulder, back, wrist, and elbow. The rising global prevalence of knee osteoarthritis, the demand for minimally invasive procedures, and the growing geriatric population are some key factors that are projected to boost the viscosupplementation market during the forecast period. Furthermore, improved healthcare infrastructure and increased awareness about viscosupplementation are expected to provide significant growth to the global viscosupplementation market.

On the other hand, the global viscosupplementation market is projected to hinder by stringent government regulations and increasing insurance denials for viscosupplementation products. However, due to the treatment effectiveness in providing relief to patients, the market for viscosupplementation in knee osteoarthritis is rapidly increasing. Patients who didn't recover from physical exercise, weight loss, or corticosteroid injections will benefit from viscosupplementation for knee procedures. As a result, this will be creating an opportunity for the growth of the market.

Segmental Outlook

The global viscosupplementation market is segmented based on product and application. Based on product the market is segmented into single-injection, three-injection, and five-injection. Further on the basis of application, the market is classified into Knee, Hip, Ankle, and others. Among product segments, the three-injection segment is projected to have significant growth in the global viscosupplementation market due to the availability of a large number of commercialized goods and a high rate of product adoption. This injection supports treating osteoarthritis, a Knee arthritis is a common form of arthritis that affects many people. It is caused when the cartilage, the smooth lining that covers the bones in the joints, breaks down. This injection is suitable for people who did not get relief from nonsteroidal anti-inflammatory drugs or people who can't take drugs due to their side effects.

Regional Outlooks

The global viscosupplementation market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to have a significant share in the global viscosupplementation market due to rising incidences of osteoarthritis in the US and Canada. The growing demand for minimally invasive viscosupplementation procedures for the treatment of knee osteoarthritis is also responsible for the market growth in the region. Furthermore, the existence of advanced healthcare infrastructure, the presence of major key players, and the demand for viscosupplementation products are likely to propel the regional market.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global Viscosupplementation market

Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global ViscosupplementationIndustry
  • Recovery Scenario of Global ViscosupplementationIndustry
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Viscosupplementation marketBy Product
    • 5.1.1. Single-Injection
    • 5.1.2. Three-Injection
    • 5.1.3. Five-Injection
  • 5.2. Global Viscosupplementation marketby Application
    • 5.2.1. Knee
    • 5.2.2. Hip
    • 5.2.3. Ankle
    • 5.2.4. Others(Shoulder, Spine)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Anika Therapeutics, Inc.
  • 7.2. Ferring B.V.
  • 7.3. Fidia Farmaceutici S.p.A
  • 7.4. Johnson & Johnson Services, Inc.
  • 7.5. KalVista Pharmaceuticals, Inc.
  • 7.6. LG Chem (Life Sciences)
  • 7.7. Lifecore Biomedical, LLC
  • 7.8. Maxigen Biotech, Inc.
  • 7.9. Pharmascience Inc.(PendoPharm)
  • 7.10. Regen Lab SA
  • 7.11. Sanofi S.A.
  • 7.12. Seikagaku Corp.
  • 7.13. Shanghai Haohai Biological Technology Co., Ltd.
  • 7.14. Smith & Nephew PLC
  • 7.15. Stellar Pharmaceuticals, Inc.
  • 7.16. Stryker Corp.
  • 7.17. Swiss Biomed Orthopaedics AG
  • 7.18. Virchow Biotech Pvt. Ltd.
  • 7.19. Zimmer Biomet Holdings, Inc.

LIST OF TABLES

  • 1. GLOBAL VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY PRODUCT,2020-2027 ($ MILLION)
  • 2. GLOBALSINGLE-INJECTIONVISCOSUPPLEMENTATIONMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 3. GLOBAL THREE-INJECTIONVISCOSUPPLEMENTATIONMARKETRESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 4. GLOBAL FIVE-INJECTIONVISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

5. GLOBALVISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY APPLICATION,

  • 6. GLOBAL VISCOSUPPLEMENTATION FOR KNEE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027($ MILLION)
  • 7. GLOBALVISCOSUPPLEMENTATION FOR HIP MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 8. GLOBALVISCOSUPPLEMENTATION FORANKLEMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL VISCOSUPPLEMENTATION FOROTHERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BYPRODUCT,2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY APPLICATION,2020-2027 ($ MILLION)
  • 14. EUROPEAN VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. EUROPEAN VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY PRODUCT,2020-2027 ($ MILLION)
  • 16. EUROPEAN VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY PRODUCT,2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD VISCOSUPPLEMENTATION MARKETRESEARCH AND ANALYSIS BY PRODUCT2020-2027 ($ MILLION)
  • 22. REST OF THE WORLD VISCOSUPPLEMENTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL VISCOSUPPLEMENTATION MARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL VISCOSUPPLEMENTATION MARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL VISCOSUPPLEMENTATION MARKET, 2020-2027 (%)
  • 4. GLOBAL VISCOSUPPLEMENTATION MARKETSHARE BY PRODUCT,2020 VS 2027 (%)
  • 5. GLOBAL VISCOSUPPLEMENTATION MARKETSHARE BY APPLICATION, 2020 VS 2027 (%)
  • 6. GLOBAL VISCOSUPPLEMENTATION MARKETSHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL SINGLE-INJECTIONVISCOSUPPLEMENTATIONMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL THREE-INJECTIONVISCOSUPPLEMENTATIONMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL FIVE-INJECTIONVISCOSUPPLEMENTATIONMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 10. GLOBALVISCOSUPPLEMENTATION FOR KNEEMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBALVISCOSUPPLEMENTATION FOR HIPMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBALVISCOSUPPLEMENTATION FORANKLE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBAL VISCOSUPPLEMENTATION FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. US VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 15. CANADA VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 16. UK VISCOSUPPLEMENTATION AND MARKET SIZE, 2020-2027($ MILLION)
  • 17. FRANCE VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 18. GERMANY VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 19. ITALY VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 20. SPAIN VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 21. REST OF EUROPE VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 22. INDIA VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 23. CHINA VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 24. JAPAN VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 25. SOUTH KOREA VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 26. REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)
  • 27. REST OF THE WORLD VISCOSUPPLEMENTATION MARKETSIZE, 2020-2027($ MILLION)